Hongbo Lu, Ph.D.

Hongbo Lu, Ph.D.

DirectoratZenas BioPharma· In proxies 2024–2025

Hongbo Lu, Ph.D. sits on 6 public boards.

Boards1

  • Zenas BioPharmaDirector · 2 yr on the boardIndependentNominating and Corporate Governance—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Zenas BioPharmaPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +59%
  2. Arrowhead PharmaceuticalsPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  3. Avedro Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Crown Bioscience Inc.Public company
    • Director? – PresentNo stock prices for these years
  5. Turning Point Therapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. Terns Pharmaceuticals Inc.Public company · 5 yr
    • Director2020 – 2025 · 5 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?